A Single Blinded Study on the Effect of Saccharomyces Boulardii CNCM I-745 on Growth and Development in Preterm Infants

NCT02310425 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Infant, Premature, Diseases

Interventions

DRUG: S. boulardii
DRUG: Placebo

Sponsor

Lingfen Xu, MD